DuPont Rated First with the Strongest Patent Portfolio in the Chemical Industry

DuPont has the strongest patent portfolio in the chemical industry, according to the Global Patent Scorecard™ issued on Oct. 21. DuPont has rated first among chemical companies since the inception of the report's publication in the Wall Street Journal. The Patent Board™ rated DuPont more than twice as strong as second place 3M for the aggregate "Technology Strength" score.

"Science is the engine of sustainable growth for DuPont," said Chief Science and Technology Officer Uma Chowdhry. "The Patent Scorecard™ validates DuPont's patent portfolio as being strongly linked to core science and shows our leadership in innovation cycle time on the latest technologies. New patent grants and patent strength are leading indicators that allow us to monitor how well we are putting our science to work."

DuPont averages more than five patent filings per day and holds an active portfolio of more than 6,000 U.S. patents. More than 1,000 new products were launched in 2007. That enabled a gain of more than USD 10 billion revenue last year from products launched since 2004. "Every new product introduction is a pricing opportunity," Uma said.

The Patent Board uses a proprietary process to evaluate patent portfolios for quality, quantity, strength, intensity, and innovation cycle time.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.